Close Menu

NEW YORK – Fluxion Biosciences said today that the National Institutes of Health awarded the firm a $284,132 Phase I research grant in September to develop its Spotlight non-invasive prenatal test. 

As part of the project, the Alameda, California-based firm will validate a model system for test development, integrate key test components, and conduct clinical testing to compare Spotlight NIPT performance to competitive NIPT screening assays. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.